The China International Talent Exchange Conference - Shenzhen Forum, hosted by the Ministry of Science and Technology and the Shenzhen Municipal People's Government, was held at the Shenzhen Convention and Exhibition Center. Numerous domestic and international experts, scholars and business elites gathered together for a top-tier forum on technological innovation and talent development.
Dr. Hu Xiang of Beike Biotech was invited to deliver a keynote speech
—— "Technological Innovation Driving the Medical Revolution"
On April 14, 2019, the 17th China International Talent Exchange Conference - Shenzhen Forum, hosted by the Ministry of Science and Technology (the State Administration of Foreign Experts Affairs) and the Shenzhen Municipal People's Government, was held at the Shenzhen Convention and Exhibition Center. Zhang Jianguo, Vice Minister of the Ministry of Science and Technology and Director of the State Administration of Foreign Experts Affairs; Liu Qingsheng, Standing Committee Member of the CPC Shenzhen Municipal Committee, Deputy Mayor and Party Group Secretary of the Shenzhen Municipal Government, as well as more than 700 experts, scholars, entrepreneurs and business elites from home and abroad, gathered together to share, in the new international landscape, ideas on the sustainable development and innovation of science, technology and talent.[1]
As a leading contributor to stem cell research and clinical translational application, Dr. Hu Xiang, Chairman of Beike Biotech, was invited to attend the forum and delivered an excellent keynote speech titled "Technological Innovation Driving the Medical Revolution," offering an in-depth interpretation of cutting-edge fields such as life sciences and the biomedical industry around three core themes — "people," "technology," and "life" — and discussing the outlook for future medicine.
(Dr. Hu Xiang, Chairman of Beike Biotech, delivers a keynote speech in the forum's "Building Core Competitiveness Through Technological Innovation" segment)
Below are highlights from Dr. Hu Xiang's speech at the forum:
Dr. Hu Xiang's wonderful sharing allowed guests to feel the charm of biotechnology and gave them confidence in the future of biopharmaceuticals and cell therapy.
At this forum, heavyweight guests including Fellows of the Royal Academy of Engineering Jim McDonald and John Speakman, "Father of the Internet of Things" Kevin Ashton, Chief Liaison Officer for Hong Kong Affairs of the Qianhai Authority Hung Wai-man, and University of Westminster Vice-Chancellor Peter Bonfield, also delivered excellent speeches.
— Beike Biotech —
Beike Biotech was founded in July 2005 and is one of China's earliest National High-Tech Enterprises specializing in the clinical translation and technology services of biotherapy technology, a strategic emerging industry.
With 14 years of focus on the cell field, Beike Biotech has a leading R&D team. To date, it has filed 82 patents in cell technology, with 33 granted; published more than 100 papers in domestic and international authoritative journals such as Cell Stem Cell; and undertaken more than 60 government projects at all levels, including 6 national-level projects (2 of which are 863 Programs).
In December 2015, the National Development and Reform Commission approved Beike Biotech to construct the "National-Local Joint Engineering Laboratory of Personalized Cell Therapy Technology." This laboratory is China's national-level technology development and translation platform for advancing the clinical translation of personalized cell therapy technology.
